ArticleCancers2024
Management of High-Risk Neuroblastoma with Soft-Tissue-Only Disease in the Era of Anti-GD2 Immunotherapy.
Maite Gorostegui et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleCancers2024
Maite Gorostegui et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.